Insider · CIK 0001573785
Michael H. Davidson
Files at TENX (TENAX THERAPEUTICS, INC.), SLN (Silence Therapeutics plc), BIOA (BioAge Labs, Inc.), NAMS (NewAmsterdam Pharma Co N.V.). First filing Sep 15, 2026, latest Sep 15, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NAMS: NewAmsterdam Pharma Co N.V.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | NAMSbuy NewAmsterdam Pharma Co N.V. | $227k 10,000 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | NAMS NewAmsterdam Pharma Co N.V. | POpen-market purchase Ordinary Shares | +10,000 | $22.65 | $227k | 792,923 | 27 d ago |
| Jun 5, 2025 | BIOA BioAge Labs, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 9, 2025 |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Ordinary Shares | +30,992 | $0.00 | $0 | 364,305 | Mar 28, 2025 |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | MOption exercise Ordinary Shares | +38,394 | $0.00 | $0 | 402,699 | Mar 28, 2025 |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | SOpen-market sale Ordinary Shares | -12,258 | - | - | 390,441 | Mar 28, 2025 |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Restricted Stock Unitderivative | +38,394 | - | - | 38,394 | Mar 28, 2025 |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | MOption exercise Restricted Stock Unitderivative | -38,394 | - | - | 0 | Mar 28, 2025 |
| Jan 7, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Ordinary Shares | +123,529 | - | - | 123,529 | Jan 7, 2025 |
| Jan 6, 2025 | NAMS NewAmsterdam Pharma Co N.V. | AGrant or award Option (right to buy)derivative | +670,467 | $0.00 | $0 | 670,467 | Jan 7, 2025 |
| Jan 2, 2025 | SLN Silence Therapeutics plc | AGrant or award Share Option (Right to Buy)derivative | +48,000 | $0.00 | $0 | 48,000 | Jan 6, 2025 |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 12, 2024 |
| Oct 9, 2024 | NAMS NewAmsterdam Pharma Co N.V. | GGift Warrant (right to buy)derivative | -15,000 | $11.50 | $173k | 85,000 | Oct 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.